June 20, 2018 / 5:10 AM / 3 months ago

BRIEF-Idorsia Initiates Precision - Phase 3 Study With Aprocitentan

June 20 (Reuters) - Idorsia Ltd:

* IDORSIA INITIATES PRECISION - PHASE 3 STUDY WITH APROCITENTAN FOR RESISTANT HYPERTENSION MANAGEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below